RubenfeldGDCaldwellEPeabodyE. Incidence and outcomes of acute lung injury. New Engl Med J2005;353: 1685–93.
2.
RubenfeldGD. Epidemiology of acute lung injury. Crit Care Med2003;31: S276–84.
3.
DowdyDWEidMPDennisonCR. Quality of life after acute respiratory distress syndrome: A meta-analysis. Intensive Care Med2006;32: 1115–24.
4.
The ARDS Network investigators. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The acute respiratory distress syndrome network. New Engl J Med2000;342: 1301–08.
5.
AdhikariNBurnsKEMeadeMO. Pharmacologic therapies for adults with acute lung injury and acute respiratory distress syndrome. Cochrane Database Syst Rev2004:CD004477.
6.
CepkovaMMatthayMA. Pharmacotherapy of acute lung injury and the acute respiratory distress syndrome. J Intensive Care Med2006;21: 119–43.
7.
McAuleyDFMatthayMA. Is there a role for beta-adrenoceptor agonists in the management of acute lung injury and the acute respiratory distress syndrome?. Treatments Resp Med2005;4: 297–307.
8.
PerkinsGDMcAuleyDFThickettDRGaoF. The beta-agonist lung injury trial (BALTI): A randomized placebo-controlled clinical trial. Am J Resp Crit Care Med2006;173: 281–87.
9.
MatthayMABrowerRThompsonBT. Randomized, placebo-controlled trial of an aerosolized beta-2 adrenergic agonist (albuterol) for the treatment of acute lung injury. Am J Resp Crit Care Med2009;179: A2166.
10.
AnzuetoABaughmanRPGuntupalliKK. Aerosolized surfactant in adults with sepsis-induced acute respiratory distress syndrome. Exosurf acute respiratory distress syndrome sepsis study group. New Engl J Med1996;334: 1417–21.
11.
TaylorRWZimmermanJLDellingerRP. Low-dose inhaled nitric oxide in patients with acute lung injury: A randomized controlled trial. JAMA2004;291: 1603–09.
12.
WareLMatthayM. Alveolar fluid clearance is impaired in the majority of patients with acute lung injury and the acute respiratory distress syndrome. Am J Resp Crit Care Med2001;163: 1376–83.